Purple Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 1YI?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,377,0000.775%
Institutions6,741,5062.2%
Hedge Funds27,066,1708.82%
General Public270,593,33488.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 46.1%.


Top Shareholders

Top 25 shareholders own 11.79% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.82%
Armistice Capital LLC
27,066,170€956.9k28%0.03%
0.68%
Kingswood Wealth Advisors, LLC
2,080,600€73.6k11.8%0.01%
0.45%
Morgan Stanley, Investment Banking and Brokerage Investments
1,366,100€48.3k57.9%no data
0.43%
Gil Efron
1,325,000€46.8k24.7%no data
0.34%
Jason Carrick
1,052,000€37.2k0%no data
0.19%
Meitav Investment House Ltd
593,354€21.0k-0.24%no data
0.19%
Citadel Advisors LLC
580,230€20.5k393%no data
0.13%
Phoenix Investments & Finances Ltd
384,093€13.6k3%no data
0.095%
XTX Holdings Limited, Asset Management Arm
290,990€10.3k115%no data
0.076%
Migdal Mutual Funds Ltd.
232,124€8.2k0.49%no data
0.07%
Millennium Management LLC
214,380€7.6k0%no data
0.052%
Virtu Financial LLC, Asset Management Arm
160,780€5.7k0%no data
0.051%
Venture Visionary Partners LLC
155,530€5.5k0%no data
0.047%
Wealth Advisors of Iowa, LLC
142,700€5.0k0%no data
0.041%
Geode Capital Management, LLC
126,660€4.5k0%no data
0.038%
UBS Asset Management AG
116,110€4.1k481%no data
0.033%
Raymond James Financial Inc., Asset Management Arm
100,000€3.5k0%no data
0.015%
Psagot Index Funds Ltd
46,927€1.7k1.18%no data
0.013%
Toronto-Dominion Bank, Banking Investments
40,000€1.4k0%no data
0.011%
Harel Insurance Investments and Finances Services Ltd, Asset Management Arm
34,048€1.2k1.24%no data
0.01%
Group One Trading LP, Asset Management Arm
32,060€1.1k-5.2%no data
0.007%
RBC Dominion Securities Inc., Asset Management Arm
21,500€760.30%no data
0.0028%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
8,590€303.70%no data
0.0023%
Simplex Trading, LLC, Asset Management Arm
7,080€250.50%no data
0.0011%
Global Retirement Partners, LLC
3,360€119.30%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/08/12 01:51
End of Day Share Price 2024/05/15 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Purple Biotech Ltd is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Emily BodnarH.C. Wainwright & Co.
Raghuram SelvarajuRodman & Renshaw, LLC